These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 30200293)

  • 1. Developmental Programming of the Metabolic Syndrome: Can We Reprogram with Resveratrol?
    Tain YL; Hsu CN
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30200293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early-Life Origins of Metabolic Syndrome: Mechanisms and Preventive Aspects.
    Hsu CN; Hou CY; Hsu WH; Tain YL
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive Aspects of Early Resveratrol Supplementation in Cardiovascular and Kidney Disease of Developmental Origins.
    Hsu CN; Hou CY; Tain YL
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational insights on developmental origins of metabolic syndrome: Focus on fructose consumption.
    Lee WC; Wu KLH; Leu S; Tain YL
    Biomed J; 2018 Apr; 41(2):96-101. PubMed ID: 29866605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Resveratrol in the Treatment of Metabolic Syndrome.
    Hou CY; Tain YL; Yu HR; Huang LT
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30695995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Syndrome Programming and Reprogramming: Mechanistic Aspects of Oxidative Stress.
    Tain YL; Hsu CN
    Antioxidants (Basel); 2022 Oct; 11(11):. PubMed ID: 36358480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Nitric Oxide Production in the Developmental Programming of Hypertension and Kidney Disease.
    Hsu CN; Tain YL
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30764498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical basis for pharmacological intervention as a reprogramming strategy against hypertension and kidney disease of developmental origin.
    Tain YL; Chan SHH; Chan JYH
    Biochem Pharmacol; 2018 Jul; 153():82-90. PubMed ID: 29309755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal Supplementation of Probiotics, Prebiotics or Postbiotics to Prevent Offspring Metabolic Syndrome: The Gap between Preclinical Results and Clinical Translation.
    Huang YH; Tain YL; Hsu CN
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay between Oxidative Stress and Nutrient Sensing Signaling in the Developmental Origins of Cardiovascular Disease.
    Tain YL; Hsu CN
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental Programming of Adult Disease: Reprogramming by Melatonin?
    Tain YL; Huang LT; Hsu CN
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28212315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMP-Activated Protein Kinase as a Reprogramming Strategy for Hypertension and Kidney Disease of Developmental Origin.
    Tain YL; Hsu CN
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutritional Approaches Targeting Gut Microbiota in Oxidative-Stress-Associated Metabolic Syndrome: Focus on Early Life Programming.
    Tain YL; Hsu CN
    Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-stress, Glial- and Neuro-differentiation Potential of Resveratrol: Characterization by Cellular, Biochemical and Imaging Assays.
    Afzal S; Garg S; Adiga D; Ishida Y; Terao K; Kaul SC; Wadhwa R
    Nutrients; 2020 Feb; 12(3):. PubMed ID: 32121454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Origins of Hypertension: Should Prevention Start Before Birth Using Natural Antioxidants?
    Hsu CN; Tain YL
    Antioxidants (Basel); 2020 Oct; 9(11):. PubMed ID: 33113999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen Sulfide in Hypertension and Kidney Disease of Developmental Origins.
    Hsu CN; Tain YL
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29751631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing Developmental Origins of Cardiovascular Disease: Hydrogen Sulfide as a Potential Target?
    Hsu CN; Tain YL
    Antioxidants (Basel); 2021 Feb; 10(2):. PubMed ID: 33562763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal Models for DOHaD Research: Focus on Hypertension of Developmental Origins.
    Hsu CN; Tain YL
    Biomedicines; 2021 May; 9(6):. PubMed ID: 34072634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental and Early Life Origins of Hypertension: Preventive Aspects of Melatonin.
    Tain YL; Hsu CN
    Antioxidants (Basel); 2022 May; 11(5):. PubMed ID: 35624788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Syndrome as a Multifaceted Risk Factor for Oxidative Stress.
    Spahis S; Borys JM; Levy E
    Antioxid Redox Signal; 2017 Mar; 26(9):445-461. PubMed ID: 27302002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.